Executive Vice President
Depaertment of Clinical Sciences
PRA Health Science
Poland
KENT THOELKE completed his education at Western Washington University. He was the Board member for CRO Joint Venture between PRA and WuXi - WuXiPRA. At present he was the acting CEO for WuxiPRA.
KENT THOELKE has broad interest in Scientific Affairs, Strategic Drug Development, Medical Affairs, Safety/Pharmacovigilance, Commercialization Services, Patient Access and Recruitment, Medical Informatics, Site Intelligence and Global Feasibility.